首页|和厚朴酚在乳腺癌细胞上皮间质转化中的作用研究

和厚朴酚在乳腺癌细胞上皮间质转化中的作用研究

扫码查看
目的 探讨和厚朴酚对乳腺癌上皮间质转化(EMT)的作用及其机制.方法 将MDA-MB-231细胞随机分为对照组(正常培养)、低剂量组(40 μmol·L-1和厚朴酚)、中剂量组(50 μmol·L-1和厚朴酚)、高剂量组(60 μmol·L-1 和厚朴酚)、si-NC 组(转染 si-NC)、si-NF2 组(转染si-NF2)、DMSO组(等剂量二甲基亚砜处理)、抑制药组(12 µmol·L-1 Hippo通路抑制药Verteporfin).用四甲基偶氮唑蓝(MTT)实验检测细胞存活情况;用Transwell实验检测细胞迁移情况;用蛋白质印迹法检测EMT相关蛋白的表达水平.将BALB/c雌性小鼠随机分为模型组(构建移植瘤模型)、低剂量实验组(建模后灌胃给予100 mg·kg-1和厚朴酚)、高剂量实验组(建模后灌胃给予200 mg·kg-1和厚朴酚),每组10只.治疗结束后检测肿瘤体积和质量,并用蛋白质印迹法检测EMT相关蛋白的表达水平.结果 对照组、低剂量组、中剂量组、高剂量组的细胞存活率分别为(100.00±4.02)%、(80.14±6.51)%、(64.05±6.21)%和(53.70±5.19)%,细胞迁移数量分别为(276.30±14.77)、(219.40±12.50)、(162.20±9.53)和(100.10±6.50)个,神经纤维蛋白 2(NF2)相对表达水平分别为 0.52±0.04、0.60±0.06、0.65±0.07 和0.78±0.10,细胞程序性死亡-配体1(PD-L1)蛋白相对表达水平分别为0.70±0.06、0.47±0.04、0.41±0.05 和0.36±0.03.低、中、高剂量组的上述指标与对照组比较,在统计学上差异均有统计学意义(均P<0.05).模型组、低剂量实验组、高剂量实验组小鼠的肿瘤体积分别为(922.02±109.61)、(743.04±64.04)和(605.00±72.63)mm3,肿瘤质量分别为(0.87±0.10)、(0.66±0.10)和(0.53±0.11)g,PD-L1 蛋白相对表达水平分别为0.74±0.08、0.51±0.05和0.42±0.05,N-钙黏着蛋白(N-cadherin)蛋白表达水平分别为0.75±0.07、0.60±0.10和0.51±0.04.低、高剂量实验组的上述指标与模型组比较,在统计学上差异均有统计学意义(均P<0.05).结论 和厚朴酚可能通过调节NF2-Hippo信号通路作用于PD-L1抑制乳腺癌细胞EMT.
Effects of honokiol on epithelial mesenchymal transformation of breast cancer cells
Objective To investigate the effect of honokiol on epithelial mesenchymal transformation(EMT)in breast cancer and its mechanism.Methods MDA-MB-231 cells were randomly divided into control group(normal culture),low dose group(40 µmol·L-1 honokiol),middle dose group(50 μmol·L-honokiol),high dose group(60 μmol·L-1 honokiol),si-NC group(transfected with si-NC),si-NF2 group(transfected with si-NF2),DMSO group(treated with dimethyl sulfoxide)and verteporfin group(12 μmol·L-1 Verteporfin,hippo pathway inhibitor).The cell survival rate of each group was detected by methyl thiazolyl tetrozolium(MTT)assay;Transwell assay detected cell migration in each group;Western blot assay was used to detect the expression of EMT-related protein.BALB/c female mice were randomly divided into model group(construct transplanted tumor model),experimental-L group(give 100 mg·kg-1 and honokiol after modeling)and experimental-H group(give 200 mg·kg-1 and honokiol after modeling),with 10 mice in each group.Tumor volume and weight were detected after treatment;Western blot assay was used to detect the expression of EMT-related proteins.Results The cell survival rates of control group,low dose group,middle dose group and high dose group were(100.00±4.02)%,(80.14±6.51)%,(64.05±6.21)%and(53.70±5.19)%;the migration number of cells were 276.30±14.77,219.40±12.50,162.20±9.53 and 100.10±6.50;the relative expression levels of neurofibrin 2(NF2)protein were 0.52±0.04,0.60±0.06,0.65±0.07 and 0.78±0.10;the relative expression levels of programmed cell death ligand 1(PD-L1)protein were 0.70±0.06,0.47±0.04,0.41±0.05 and 0.36±0.03,respectively.The above indexes in low,middle and high dose groups were significantly different from those in control group(all P<0.05).The tumor volume of model group,experimental-L group and experimental-H group were(922.02±109.61),(743.04±64.04)and(605.00±72.63)mm3;the tumor weight were(0.87±0.10),(0.66±0.10)and(0.53±0.11)g;the relative expression levels of PD-L1 protein were 0.74±0.08,0.51±0.05 and 0.42±0.05;the relative expression levels of N-cadherin protein were 0.75±0.07,0.60±0.10 and 0.51±0.04,respectively.The above indexes in the experimental-L,-H groups were significantly different from those in the model group(all P<0.05).Conclusion Honokiol may inhibit EMT in breast cancer cells by regulating NF2-hippo signaling pathway in PD-L1.

honokiolbreast cancerneurofibrin 2-hippo/Yes associated protein 1 pathwayprogrammed cell death-ligand 1epithelial mesenchymal transformation

李谌、王钰

展开 >

锦州医科大学附属第一医院分子检测中心,辽宁锦州 121000

和厚朴酚 乳腺癌 神经纤维蛋白2-Hippo/Yes相关蛋白1通路 细胞程序性死亡-配体1 上皮间质转化

辽宁省教育厅基金资助项目锦州医科大学横向课题基金资助项目

LJKZ08072021005

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(17)